Stock screener

PHAT

Conviction 13HealthcareScan · Thu, Sep 24, 2026

Phathom Pharmaceuticals, Inc. (PHAT) closed at $7.07 (+1.22%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 32, RS Rating 12, -60.9% from its 52-week high, -55.0% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

PHAT$7.07+1.22%
ResistanceSupportVol 14
63 bars
Vol MA14 1.44M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Phathom Pharmaceuticals, Inc.PHARMACEUTICAL PREPARATIONSwww.phathompharma.com ↗
Price7.07
Change+1.22%
Gap-0.07%
Rel volume1.65×
Avg volume1.29M
Avg $ vol10.66M
SMA 208.44
SMA 509.19
SMA 20011.62
Price vs 50-23.07%
Price vs 200-39.18%
MA stackbearish
50/200 cross—
Supertrenddown · 8.51
RSI (14)32
MACD hist-0.12
MACD crossbear · 9d
Stoch %K / %D6 / 8
ADX (14)25
+DI / −DI13 / 31
RSI divergence—
MACD divergence—
ATR %7.14%
ADR %5.84%
52w high18.08
52w low6.99
From 52w high-60.90%
Above 52w low+1.22%
New 52w highNo
SqueezeOff
Bollinger width39.27%
%B0.09
Donchian pos5.67%
Donchian high9.73
Donchian low6.91
AVWAP (52w high)11.21
vs AVWAP high-36.92%
AVWAP (52w low)7.05
vs AVWAP low+0.24%
OBV trendFlat
Chaikin MF (20)-0.11
Today vs 20d1.65×
Avg vol (14d)1.44M
Avg vol (20d)1.29M
Avg $ vol (20d)10.66M
Market cap571.97M
RS Rating12 / 99
RS 3m (vs SPY)-36.12%
RS 6m (vs SPY)-49.29%
RS line new highNo
Trend template0/8
Technical rank9.2
1 week-8.77%
1 month-19.66%
3 months-31.62%
6 months-32.47%
1 year-40.59%
YTD-55.00%
P/E-2.59
P/B-1.66
P/S3.27
P/FCF-3.42
EPS-3.03
Div yield—
ROE64.27%
ROA-67.64%
Debt/Eq-0.48
Current1.92
EV/EBITDA-3.48
Gross margin87.09%
Net margin-126.35%
Rev growth216.93%
EPS growth33.82%
Price target19.29
Target upside172.84%
Analyst ratingBuy
Institutional93.05%
Ent. value554.08M
Revenue74.27M
Net income-17.58M
Gross profit59.18M
Free cash flow-167M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out79.76M
Employees371
ListedFri, Oct 25, 2019
Free float42.17M
Float %53.5%
Short interest10.82M
Days to cover11.0d
Short volume65.8%
Squeeze score92 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.08 vs −$0.15
Last surprise+46.7% beat
Setup gradeD
Conviction13 / 100
Pattern quality—
Tech rank9.2 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance9.71
Support8.14
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in PHAT

All disclosures →
No recent disclosed trades by Congress in PHAT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PHAT

InsiderSideShares
Breedlove Robert Charles
Principal Accounting Officer · Common Stock · 2026-07-14
Tax1.55K
Parikh Asit
Director · Common Stock · 2026-05-22
Gift28K
Parikh Asit
Director · Common Stock · 2026-05-22
Gift28K
Parikh Asit
Director · Common Stock · 2026-05-20
Exercise17.5K
Parikh Asit
Director · Common Stock (Right to Buy) · 2026-05-20
Disposition17.5K
Topper James N
Director · Common Stock · 2026-05-19
Other—
Schroeder Theodore R
Director · Common Stock · 2026-05-19
Grant24.12K
FIELDS HEIDI
Director · Common Stock · 2026-05-19
Grant24.12K
KARBE FRANK
Director · Common Stock · 2026-05-19
Grant24.12K
Parikh Asit
Director · Common Stock · 2026-05-19
Other—

SEC filings

EDGAR filings in PHAT · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.